eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | precocious puberty |
| Comorbidity | C0242292|mccune-albright syndrome |
| Sentences | 2 |
| PubMedID- 22999294 | The objective of this study was to evaluate the safety and efficacy of fulvestrant (faslodextm), a pure estrogen receptor antagonist, in girls with progressive precocious puberty (pp) associated with mccune-albright syndrome (mas). |
| PubMedID- 22051789 | Summary and conclusion: although different in presentation, all three atypical cases of suspected mccune-albright syndrome with gonadotropin-independent precocious puberty were successfully treated with aromatase inhibitors. |
Page: 1